FRANKFURT, Nov 28 (Reuters) - Switzerland's Novartis said on Tuesday it was targeting annual sales growth rates of 5% until 2027 and a core operating income margin of about 40% by 2027. (Reporting by Ludwig Burger Editing by Miranda Murray)